Acelyrin price target lowered to $6 from $13 at Morgan Stanley
PremiumThe FlyAcelyrin price target lowered to $6 from $13 at Morgan Stanley
3M ago
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
Premium
The Fly
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
3M ago
Acelyrin price target lowered to $20 from $68 at Piper Sandler
Premium
The Fly
Acelyrin price target lowered to $20 from $68 at Piper Sandler
3M ago
Wells upgrades Acelyrin to Overweight with shares trading below cash
PremiumThe FlyWells upgrades Acelyrin to Overweight with shares trading below cash
4M ago
Acelyrin upgraded to Overweight from Equal Weight at Wells Fargo
Premium
The Fly
Acelyrin upgraded to Overweight from Equal Weight at Wells Fargo
4M ago
Acelyrin to present 16-week data from Phase 2b/3 trial of izokibep
Premium
The Fly
Acelyrin to present 16-week data from Phase 2b/3 trial of izokibep
5M ago
ACELYRIN, INC. Appoints Mina Kim as New CEO
PremiumCompany AnnouncementsACELYRIN, INC. Appoints Mina Kim as New CEO
6M ago
Acelyrin provides business and milestone update
Premium
The Fly
Acelyrin provides business and milestone update
6M ago
Acelyrin CEO Shao-Lee Lin steps down, Mina Kim succeeding
Premium
The Fly
Acelyrin CEO Shao-Lee Lin steps down, Mina Kim succeeding
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100